New research indicates that ThinOgen Plus is effective in controlling body weight and fat, according to Beijing Gingko Group (BGG). A proprietary blend of fucoxanthin and other ingredients, ThinOgen Plus was administered in a randomized clinical trial to 19 subjects for 3 months to measure and assess its weight and fat loss effects. Comprised of males and seven females ages 25-50 years old, the subjects were in the body mass index (BMI) range of 23 to 40 kg/m2 and free of severe metabolic disease demanding medical control, cancer, malnutrition, pregnancy or lactation and other anti-obesity products used within the prior 3 months. Control group subjects received a placebo, with the balance receiving various dosages of ThinOgen Plus.
After the first month, nearly 93% of the 2 mg/d group and 95% of the 4 mg/d group reported weight and fat loss. After the second month, 93% of the 2 mg/d group and 95% of the 4 mg/d group reported loss. After the third month, 94.5% of the 2 mg/d group and 99% of the 4 mg/d group reported loss compared to the placebo group. During the fourth month, supplementation was halted, but weight and fat loss continued for the 2 mg/d and 4 mg/d groups. Further, CT scans measured the subjects’ abdominal fat areas and determined a strong likelihood for continued fat loss. For further information: www.bggusa.com